account_id none on file
legal_name CNS Pharmaceuticals, Inc.
ticker CNSP
cik 1729427
domain cnspharma.com
linkedin_company_url https://www.linkedin.com/company/cnspharma
entry_point_account_id none on file
name CNS Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 19 executives 9 family 0
why_nownone on file
callsnone on file
filings
similarly situated executives, expense reimbursement in accordance with Company policy, and other standard benefits. Under the Employment Agreement, if Mr.
filing / Aug 21, 2026 / receipt
executives, expense reimbursement in accordance with Company policy, and other standard benefits. Under the Employment Agreement, if Dr.
filing / Aug 21, 2026 / receipt
Downs agreed to resign as Chief Financial Officer effective March 2, 2026 and to serve as the Company’s Senior Vice President
filing / Aug 21, 2026 / receipt
“householding,” potentially means extra convenience for stockholders and cost savings for companies. This year, a number of brokers with account holders who are the Company’s stockholders may be “householding” our proxy materials.
filing / Aug 21, 2026 / receipt
as the Company’s Chief Financial Officer effective March 2, 2026. The O’Loughlin Employment Agreement provides for an initial
filing / Aug 21, 2026 / receipt
Michal Fisher 39 Director
filing / Aug 21, 2026 / receipt
Jeffry R. Keyes 53 Director
filing / Aug 21, 2026 / receipt
Bettina Cockroft 59 Director
filing / Aug 21, 2026 / receipt
Amy Mahery 49 Director
filing / Aug 21, 2026 / receipt
Rami Levin, MBA - Chief Executive Officer and Director .
filing / Aug 21, 2026 / receipt
Steve O’Loughlin, MBA - Chief Financial Officer .
filing / Aug 21, 2026 / receipt
Eric Faulkner, MSc, MBA - Chief Technology Officer .
filing / Aug 21, 2026 / receipt
executives
| Amy Mahery | Director nominee | - | receipt |
| Bettina Cockroft | Director nominee | - | receipt |
| Eric Faulkner, MSc, MBA | Chief Technology Officer | - | receipt |
| Faith L. Charles | Director and Chair of the Board of Directors | - | receipt |
| Jeffry R. Keyes | Director nominee | - | receipt |
| Lynne Kelley | Chief Medical Officer | - | receipt |
| Michal Fisher | Director nominee | - | receipt |
| Rami Levin, MBA | President & Chief Executive Officer | - | receipt |
| Steve O’Loughlin | Chief Financial Officer | receipt |
familynone on file
upcoming
| 2026-11-13 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug cns-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$